HealthEquity (NASDAQ:HQY) Shares Unloaded Rep. Josh Gottheimer

Representative Josh Gottheimer (D-New Jersey) recently sold shares of HealthEquity, Inc. NASDAQ: HQY. In a filing disclosed on December 05th, the Representative disclosed that they had sold between $1,001 and $15,000 in HealthEquity stock on November 7th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Regeneron Pharmaceuticals NASDAQ: REGN on 11/29/2024.
• Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 11/27/2024.
• Sold $1,001 - $15,000 in shares of Netflix NASDAQ: NFLX on 11/27/2024.
• Sold $1,001 - $15,000 in shares of Vertiv NYSE: VRT on 11/27/2024.
• Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 11/26/2024.
• Purchased $1,001 - $15,000 in shares of Dominion Energy NYSE: D on 11/26/2024.
• Purchased $1,001 - $15,000 in shares of Johnson & Johnson NYSE: JNJ on 11/26/2024.
• Sold $1,001 - $15,000 in shares of Eaton NYSE: ETN on 11/25/2024.
• Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 11/22/2024.
• Purchased $1,001 - $15,000 in shares of Johnson & Johnson NYSE: JNJ on 11/22/2024.

HealthEquity Stock Performance

HealthEquity stock traded down $0.64 during midday trading on Friday, hitting $100.21. The stock had a trading volume of 885,402 shares, compared to its average volume of 707,893. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The company has a market capitalization of $8.75 billion, a PE ratio of 83.51, a P/E/G ratio of 1.61 and a beta of 0.55. The firm's fifty day moving average is $92.42 and its two-hundred day moving average is $83.61. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. On average, research analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP purchased a new stake in shares of HealthEquity in the 3rd quarter worth $638,000. Vaughan Nelson Investment Management L.P. lifted its stake in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after acquiring an additional 226,563 shares during the period. Natixis Advisors LLC lifted its stake in HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock worth $17,122,000 after acquiring an additional 48,009 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in HealthEquity by 29.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company's stock worth $5,535,000 after acquiring an additional 14,573 shares in the last quarter. Finally, Holocene Advisors LP purchased a new position in HealthEquity during the 3rd quarter valued at about $1,246,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity

In other news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the business's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

HQY has been the topic of several recent analyst reports. Royal Bank of Canada reissued an "outperform" rating and set a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. BTIG Research upped their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Mizuho initiated coverage on shares of HealthEquity in a report on Wednesday. They set an "outperform" rating and a $126.00 price objective for the company. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Finally, Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $109.64.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer's career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer's committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.